Sigma-Aldrich Licenses from NeuroSurvival Technologies a Marker for Molecular Imaging of Apoptosis in Vivo

News   Feb 27, 2008

 
Sigma-Aldrich Licenses from NeuroSurvival Technologies a Marker for Molecular Imaging of Apoptosis in Vivo
 
 
 

RELATED ARTICLES

Artificial Enzyme Can Catalyze Reactions

News

Artificial Biology has taken a step forward as a study shows the catalytic ability of a synthetic enzyme.

READ MORE

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

Longevity Protein Could Help Treat Diabetes

News

beta-Klotho, a protein that regulates longevity, could have therapeutic potential for diabetes and obesity.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE